
Clorox used its involvement in national standard-setting organizations to develop and file an early patent application and create a monopoly for its Brita water filter, a rival startup alleges in a new lawsuit.
Water filtration startup Zero Technologies filed the anti-competition lawsuit against Brita and The Clorox Oct. 6 in a Pennsylvania federal court, alleging violations of federal antitrust laws.
According to the lawsuit, Clorox — which makes the Brita water filter — used its involvement in the industry’s standard-setting organizations to secretly plan and execute a “patent ambush” for water filters, using information gathered through the standards bodies.
The lawsuit alleges that the Brita patent licensing conspiracy dates back to 2007.
It was then that the National Sanitation Foundation (NSF International) and the American National Standards Institute (ANSI) issued guidelines for what kind of health standards would be required for water filter makers to receive certifications, the lawsuit says.
Brita allegedly participated in the guidelines process and then used that knowledge to “develop a patent essential to the standard and lay its plan for a patent ‘ambush’ of the industry after over a decade of ongoing deception,” the lawsuit claims.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world. Clorox & Brita
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas